---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-175077"
form_type: "8-K"
ticker: "MEDP"
cik: "0001668397"
company_name: "Medpace Holdings, Inc."
filed_at: "2024-07-03T23:59:59+00:00"
generated_at: "2026-05-31T23:30:17.865011+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Medpace director Ashley Keating resigns; Dr. Dani Zander elected to board

## Summary
- Ashley M. Keating resigned from the Board effective June 30, 2024, with no disagreement on operations, policies, or practices.
- Dr. Dani S. Zander elected as Class III director effective July 1, 2024, and appointed to the Nominating and Governance Committee.
- Dr. Zander is Chair of Pathology at University of Cincinnati, formerly at Penn State, and has served as president of multiple pathology societies.
- Dr. Zander received an option to purchase 824 shares at the July 1, 2024 closing price, with a 7-year term, under standard non-employee director compensation.

## SEC filing metadata
- accession: 0001193125-24-175077
- form_type: 8-K
- ticker: MEDP
- cik: 0001668397
- company_name: Medpace Holdings, Inc.
- filed_at: 2024-07-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1668397/000119312524175077/0001193125-24-175077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1668397/000119312524175077/d822266d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-175077
- JSON: https://secwatch.observer/filing/0001193125-24-175077.json
- Plain text: https://secwatch.observer/filing/0001193125-24-175077.txt

## Key facts
- Executive change
  Ashley M. Keating resigned as Director at Medpace Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: On June 28, 2024, Ashley M. Keating, a member of the Board of Directors (the “Board”) of Medpace Holdings, Inc. (the “Company”) notified the Company of her resignation, effective as of June 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1668397/000119312524175077/0001193125-24-175077-index.htm
- Executive change
  Dani S. Zander was elected as Director at Medpace Holdings, Inc..
  - Action: elected
  - Role: Director
  source text: The Board of the Company following a recommendation from the independent directors of the Board, unanimously approved that Dr. Dani S. Zander be elected to fill the Class III director vacancy on the Board of the Company, effective July 1, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1668397/000119312524175077/0001193125-24-175077-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.